Objective: A rise in carcinoembryonic antigen level is commonly encountered during follow-up of patients with colorectal carcinoma. This study aimed to evaluate the diagnostic performance of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (18 F-FDG PET/CT) studies for detection of recurrent or metastatic colorectal carcinoma in patients with rising carcinoembryonic antigen levels. Methods: Patients with colorectal carcinoma in clinical remission with rising carcinoembryonic antigen levels who underwent PET/CT in Prince of Wales Hospital, Hong Kong from 2008 to 2011 were included. Patient demographics, carcinoembryonic antigen levels, and clinical follow-up data were recorded. Outcomes were determined by histopathological findings or at least 12-month follow-up. Results: Forty-two PET/CT studies of 37 patients (16 men and 21 women; mean [standard deviation] age, 65.8 [11.6] years) were included. Carcinoembryonic antigen levels ranged from 1.8 to 45 µg/l (9 patients had normal carcinoembryonic antigen levels of <5 µg/l, but serial carcinoembryonic antigen measurements showed a rising trend). Among the 42 events, 23 (55%) had a positive final diagnosis. The sensitivity, specificity, and positive and negative predictive values of PET/CT for recurrence or metastases were 91.3%, 89.5%, 91.3%, and 89.5%. Conclusion: 18 F-FDG PET/CT is a useful imaging modality to evaluate recurrence or metastases in patients with colorectal carcinoma in clinical remission but showing rising carcinoembryonic antigen levels.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.